Stay updated on Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Sign up to get notified when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.

Latest updates to the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now reflects a new software revision (v3.6.6) replacing the previous revision (v3.6.5). This indicates a small maintenance update to the site without substantive content changes to the study details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAn HTML error page is now shown, indicating the content is temporarily unavailable. This replaces the previously visible study record details and attachments with an error screen.SummaryDifference20%

- Check51 days agoChange DetectedThe site revision updated from v3.6.3 to v3.6.4, signaling a minor software update behind the pages with no visible changes to study details.SummaryDifference0.0%

- Check72 days agoChange DetectedThe revision label updated from v3.6.2 to v3.6.3. This indicates a minor deployment update and does not change the study details on the page.SummaryDifference0.0%

- Check79 days agoChange Detected- The page's revision indicator was updated from v3.6.0 to v3.6.2, reflecting a new build. This signals a small site update without altering the study content or primary features.SummaryDifference0.0%

- Check93 days agoChange DetectedThe study page now explicitly states that recruitment has ended ('No longer looking for participants'). It also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) to guide users in understanding the study record and participation steps.SummaryDifference0.5%

Stay in the know with updates to Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.